Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries (StratMed-MINOCA)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 379 participants.
Also called NCT05198791
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 379 participants
- Registry
-
NCT05198791
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05198791. Randomized; double masking; primary purpose treatment. Start 2022-02-04 (actual); primary completion 2026-11-18 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries (StratMed-MINOCA)
- Acronym
- StratMedMINOCA
- Condition
- Myocardial Infarction, Acute
- Condition
- Myocardial Infarction With Nonobstructive Coronary Arteries
- Condition
- Myocardial Injury
- Intervention (Drug)
- Stratified medicine - Microvascular dysfunction and eplerenone therapy, tablets
- Intervention (Other)
- Stratification and standard care
- Lead sponsor
- NHS National Waiting Times Centre Board
- Collaborator
- British Heart Foundation
- Collaborator
- Abbott
Record details
- Record id
cardio:ct-nct05198791- Content hash
2f0da36768b2361ec96f14f0291652a21549507035ac087861d9818bb3df3bdf